BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24915781)

  • 21. Psychometric properties of fatigue severity scale in Chinese systemic lupus erythematosus patients.
    Feng C; He Q; Wu Y; Hu X; Wu J; He X; Zhao S
    Health Qual Life Outcomes; 2019 Apr; 17(1):71. PubMed ID: 31014340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric properties of an Arabic version of the fatigue severity scale in patients with stroke.
    Abdulla FA; Al-Khamis FA; Alsulaiman AA; Alshami AM
    Top Stroke Rehabil; 2019 Sep; 26(6):448-455. PubMed ID: 31189456
    [No Abstract]   [Full Text] [Related]  

  • 23. Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.
    Dieterich D; Rockstroh JK; Orkin C; Gutiérrez F; Klein MB; Reynes J; Shukla U; Jenkins A; Lenz O; Ouwerkerk-Mahadevan S; Peeters M; De La Rosa G; Tambuyzer L; Jessner W
    Clin Infect Dis; 2014 Dec; 59(11):1579-87. PubMed ID: 25192745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
    Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.
    Pearlman BL; Ehleben C; Perrys M
    Gastroenterology; 2015 Apr; 148(4):762-70.e2; quiz e11-2. PubMed ID: 25557952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
    Burden AD; Bissonnette R; Anatchkova M; Budhiarso I; Skalicky AM; Liberato ACS; Hu N; Thoma C; Gloede T; Kohlmann T; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1383-1390. PubMed ID: 38334243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.
    Aronson KI; Martin-Schwarze AM; Swigris JJ; Kolenic G; Krishnan JK; Podolanczuk AJ; Kaner RJ; Martinez FJ; Safford MM; Pinheiro LC;
    Am J Respir Crit Care Med; 2023 Jul; 208(2):188-195. PubMed ID: 37099412
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the psychometric properties of two fatigue scales in multiple sclerosis.
    Amtmann D; Bamer AM; Noonan V; Lang N; Kim J; Cook KF
    Rehabil Psychol; 2012 May; 57(2):159-66. PubMed ID: 22686554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.
    Fu R; Cui SS; Du JJ; Huang P; He YC; Gao C; Luo XG; Chen SD
    Brain Behav; 2017 Jun; 7(6):e00712. PubMed ID: 28638717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016-2020.
    Vold JH; Gjestad R; Aas CF; Meland E; Johansson KA; Fadnes LT;
    Health Qual Life Outcomes; 2021 Mar; 19(1):69. PubMed ID: 33653349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct validity and test-retest reliability of the Fatigue Severity Scale in people with chronic neck pain.
    Takasaki H; Treleaven J
    Arch Phys Med Rehabil; 2013 Jul; 94(7):1328-34. PubMed ID: 23274223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the fatigue severity scale in Croatian population of patients with multiple sclerosis disease: Factor structure, internal consistency, and correlates.
    Jerković A; Proroković A; Matijaca M; Katić AĆ; Košta V; Mihalj M; Dolić K; Đogaš Z; Vidaković MR
    Mult Scler Relat Disord; 2022 Feb; 58():103397. PubMed ID: 35216780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of an Arabic version of Fatigue Severity Scale.
    Al-Sobayel HI; Al-Hugail HA; AlSaif RM; Albawardi NM; Alnahdi AH; Daif AM; Al-Arfaj HF
    Saudi Med J; 2016 Jan; 37(1):73-8. PubMed ID: 26739978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
    Hassanein T; Cooksley G; Sulkowski M; Smith C; Marinos G; Lai MY; Pastore G; Trejo-Estrada R; Horta E Vale A; Wintfeld N; Green J
    J Hepatol; 2004 Apr; 40(4):675-81. PubMed ID: 15030985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric evaluation of the Fatigue Severity Scale in patients with major depression.
    Ferentinos P; Kontaxakis V; Havaki-Kontaxaki B; Dikeos D; Lykouras L
    Qual Life Res; 2011 Apr; 20(3):457-65. PubMed ID: 20953713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigue in Pregnancy: The validity and reliability of the Farsi Multidimensional Assessment of Fatigue scale.
    Mortazavi F; Borzoee F
    Sultan Qaboos Univ Med J; 2019 Feb; 19(1):e44-e50. PubMed ID: 31198595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation and adaptation of the fatigue severity scale for use in Portugal.
    Laranjeira CA
    Appl Nurs Res; 2012 Aug; 25(3):212-7. PubMed ID: 22698652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.
    Manns MP; Fried MW; Zeuzem S; Jacobson IM; Forns X; Poordad F; Peeters M; Fu M; Lenz O; Ouwerkerk-Mahadevan S; Jessner W; Scott JA; Kalmeijer R; De La Rosa G; Sinha R; Beumont-Mauviel M
    J Viral Hepat; 2015 Apr; 22(4):366-75. PubMed ID: 25363449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.
    Finkelstein FO; van Nooten F; Wiklund I; Trundell D; Cella D
    Health Qual Life Outcomes; 2018 May; 16(1):111. PubMed ID: 29855366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.